ResearcherShanghai Jiao Tong UniversityActive in the last 2 years
Zhuoxin Wang
Matched on ORCID iD 0000-0002-9269-5000; OpenAlex author ID A5015695120. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 2 papers · 2026: 1 paper
Papers 5
- A SUZ12-marked epithelial dedifferentiation state with immune co-expression in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.compbiolchem.2026.109208↗
- Isoleucyl-tRNA synthetase 2 promotes pancreatic ductal adenocarcinoma proliferation and metastasis by stabilizing β-catenin. Co-author DOI 10.1016/j.gendis.2024.101382↗
- Targeting MTPN sensitizes pancreatic cancer of wild-type BRCA1/2 to Cisplatin-based chemotherapy. Co-author DOI 10.1038/s41417-025-00925-5↗
- IL-2 promotes expansion and intratumoral accumulation of tumor infiltrating dendritic cells in pancreatic cancer. Co-author DOI 10.1007/s00262-024-03669-7↗
- Up-Regulated MISP Is Associated With Poor Prognosis and Immune Infiltration in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fonc.2022.827051↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Lifu Wang · 4 shared papers, 2022–2025 · strength 0.98
- Paper Isoleucyl-tRNA synthetase 2 promotes pancreatic ductal adenocarcinoma proliferation and metastasis by stabilizing β-cat… DOI 10.1016/j.gendis.2024.101382↗
- Paper IL-2 promotes expansion and intratumoral accumulation of tumor infiltrating dendritic cells in pancreatic cancer. DOI 10.1007/s00262-024-03669-7↗
- Paper Targeting MTPN sensitizes pancreatic cancer of wild-type BRCA1/2 to Cisplatin-based chemotherapy. DOI 10.1038/s41417-025-00925-5↗
- Xinyang Huang · 3 shared papers, 2022–2025 · strength 0.72
- Paper Isoleucyl-tRNA synthetase 2 promotes pancreatic ductal adenocarcinoma proliferation and metastasis by stabilizing β-cat… DOI 10.1016/j.gendis.2024.101382↗
- Paper IL-2 promotes expansion and intratumoral accumulation of tumor infiltrating dendritic cells in pancreatic cancer. DOI 10.1007/s00262-024-03669-7↗
- Paper Up-Regulated MISP Is Associated With Poor Prognosis and Immune Infiltration in Pancreatic Ductal Adenocarcinoma. DOI 10.3389/fonc.2022.827051↗
- Yixun Jin · 3 shared papers, 2022–2025 · strength 0.72
- Paper Isoleucyl-tRNA synthetase 2 promotes pancreatic ductal adenocarcinoma proliferation and metastasis by stabilizing β-cat… DOI 10.1016/j.gendis.2024.101382↗
- Paper Targeting MTPN sensitizes pancreatic cancer of wild-type BRCA1/2 to Cisplatin-based chemotherapy. DOI 10.1038/s41417-025-00925-5↗
- Paper Up-Regulated MISP Is Associated With Poor Prognosis and Immune Infiltration in Pancreatic Ductal Adenocarcinoma. DOI 10.3389/fonc.2022.827051↗
- Tingting Gong · 2 shared papers, 2024–2025 · strength 0.51
- Qi Wang · 2 shared papers, 2022–2025 · strength 0.47
- Paper Isoleucyl-tRNA synthetase 2 promotes pancreatic ductal adenocarcinoma proliferation and metastasis by stabilizing β-cat… DOI 10.1016/j.gendis.2024.101382↗
- Paper Up-Regulated MISP Is Associated With Poor Prognosis and Immune Infiltration in Pancreatic Ductal Adenocarcinoma. DOI 10.3389/fonc.2022.827051↗
- Zilin Yang · 1 shared paper, 2026 · strength 0.39
- Xuejiao Wu · 1 shared paper, 2026 · strength 0.39
- Qi Wang · 1 shared paper, 2024 · strength 0.26
- Qi Wang · 1 shared paper, 2025 · strength 0.26
- Liangchao Zhao · 1 shared paper, 2022 · strength 0.16
- Hui Xu · 1 shared paper, 2022 · strength 0.16
- Tong Li · 1 shared paper, 2022 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.